It has been reported that miR-182 was upregulated in a Chinese cohort of patients with relapsing and remitting multiple sclerosis (RRMS), which is associated with the increase of IFNγ-expressing Th1 cells (27). The gene discussed is IFNG; the disease is relapsing-remitting multiple sclerosis.